![Logo](/assets/logo-d3f1fdf60522f0983e71f9fcc720cb7da5b55c0b748ed5bded3d2fbf81387bf0.png)
PMC:7253482 / 17556-17810
Annnotations
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"602","span":{"begin":3,"end":9},"obj":"Chemical"},{"id":"656","span":{"begin":35,"end":38},"obj":"Gene"},{"id":"661","span":{"begin":29,"end":34},"obj":"Species"},{"id":"671","span":{"begin":157,"end":163},"obj":"Chemical"}],"attributes":[{"id":"A602","pred":"tao:has_database_id","subj":"602","obj":"MESH:D011134"},{"id":"A656","pred":"tao:has_database_id","subj":"656","obj":"Gene:64006"},{"id":"A661","pred":"tao:has_database_id","subj":"661","obj":"Tax:11676"},{"id":"A671","pred":"tao:has_database_id","subj":"671","obj":"MESH:D011134"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"RS glycan shields by cryo-EM\nHIV-1 Env is a prototypic viral class I fusion protein that exhibits extensive surface glycosylation, resulting in an effective glycan shield to aid evasion from the host adaptive immune response21,31. In order to visualize t"}
LitCovid-PD-FMA-UBERON
{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T100","span":{"begin":29,"end":32},"obj":"Body_part"},{"id":"T101","span":{"begin":76,"end":83},"obj":"Body_part"}],"attributes":[{"id":"A100","pred":"fma_id","subj":"T100","obj":"http://purl.org/sig/ont/fma/fma278683"},{"id":"A101","pred":"fma_id","subj":"T101","obj":"http://purl.org/sig/ont/fma/fma67257"}],"text":"RS glycan shields by cryo-EM\nHIV-1 Env is a prototypic viral class I fusion protein that exhibits extensive surface glycosylation, resulting in an effective glycan shield to aid evasion from the host adaptive immune response21,31. In order to visualize t"}
LitCovid-PD-CLO
{"project":"LitCovid-PD-CLO","denotations":[{"id":"T103","span":{"begin":42,"end":43},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"RS glycan shields by cryo-EM\nHIV-1 Env is a prototypic viral class I fusion protein that exhibits extensive surface glycosylation, resulting in an effective glycan shield to aid evasion from the host adaptive immune response21,31. In order to visualize t"}
LitCovid-PD-CHEBI
{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T192","span":{"begin":26,"end":28},"obj":"Chemical"},{"id":"T193","span":{"begin":76,"end":83},"obj":"Chemical"}],"attributes":[{"id":"A192","pred":"chebi_id","subj":"T192","obj":"http://purl.obolibrary.org/obo/CHEBI_73507"},{"id":"A193","pred":"chebi_id","subj":"T193","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"}],"text":"RS glycan shields by cryo-EM\nHIV-1 Env is a prototypic viral class I fusion protein that exhibits extensive surface glycosylation, resulting in an effective glycan shield to aid evasion from the host adaptive immune response21,31. In order to visualize t"}
LitCovid-sample-PD-IDO
{"project":"LitCovid-sample-PD-IDO","denotations":[{"id":"T49","span":{"begin":195,"end":199},"obj":"http://purl.obolibrary.org/obo/IDO_0000531"}],"text":"RS glycan shields by cryo-EM\nHIV-1 Env is a prototypic viral class I fusion protein that exhibits extensive surface glycosylation, resulting in an effective glycan shield to aid evasion from the host adaptive immune response21,31. In order to visualize t"}
LitCovid-sample-Enju
{"project":"LitCovid-sample-Enju","denotations":[{"id":"T1365","span":{"begin":3,"end":9},"obj":"NN"},{"id":"T1366","span":{"begin":10,"end":17},"obj":"NNS"},{"id":"T1367","span":{"begin":18,"end":20},"obj":"IN"},{"id":"T1368","span":{"begin":21,"end":28},"obj":"NN"},{"id":"T8430","span":{"begin":29,"end":34},"obj":"NN"},{"id":"T3174","span":{"begin":35,"end":38},"obj":"NN"},{"id":"T27555","span":{"begin":39,"end":41},"obj":"VBZ"},{"id":"T55541","span":{"begin":42,"end":43},"obj":"DT"},{"id":"T20248","span":{"begin":44,"end":54},"obj":"JJ"},{"id":"T67286","span":{"begin":55,"end":60},"obj":"JJ"},{"id":"T69498","span":{"begin":61,"end":66},"obj":"NN"},{"id":"T3932","span":{"begin":67,"end":68},"obj":"CD"},{"id":"T49427","span":{"begin":69,"end":75},"obj":"NN"},{"id":"T80657","span":{"begin":76,"end":83},"obj":"NN"},{"id":"T46816","span":{"begin":84,"end":88},"obj":"WDT"},{"id":"T99370","span":{"begin":89,"end":97},"obj":"VBZ"},{"id":"T82158","span":{"begin":98,"end":107},"obj":"JJ"},{"id":"T40184","span":{"begin":108,"end":115},"obj":"NN"},{"id":"T83381","span":{"begin":116,"end":129},"obj":"NN"},{"id":"T34922","span":{"begin":129,"end":130},"obj":"-COMMA-"},{"id":"T41135","span":{"begin":131,"end":140},"obj":"VBG"},{"id":"T52094","span":{"begin":141,"end":143},"obj":"IN"},{"id":"T41086","span":{"begin":144,"end":146},"obj":"DT"},{"id":"T24478","span":{"begin":147,"end":156},"obj":"JJ"},{"id":"T12116","span":{"begin":157,"end":163},"obj":"NN"},{"id":"T66049","span":{"begin":164,"end":170},"obj":"NN"},{"id":"T24089","span":{"begin":171,"end":173},"obj":"TO"},{"id":"T80516","span":{"begin":174,"end":177},"obj":"VB"},{"id":"T40146","span":{"begin":178,"end":185},"obj":"NN"},{"id":"T31245","span":{"begin":186,"end":190},"obj":"IN"},{"id":"T10149","span":{"begin":191,"end":194},"obj":"DT"},{"id":"T79574","span":{"begin":195,"end":199},"obj":"NN"},{"id":"T93688","span":{"begin":200,"end":208},"obj":"JJ"},{"id":"T94198","span":{"begin":209,"end":215},"obj":"JJ"},{"id":"T10989","span":{"begin":216,"end":229},"obj":"NN"},{"id":"T32196","span":{"begin":231,"end":233},"obj":"IN"},{"id":"T81817","span":{"begin":234,"end":239},"obj":"NN"},{"id":"T91723","span":{"begin":240,"end":242},"obj":"TO"},{"id":"T52822","span":{"begin":243,"end":252},"obj":"VB"}],"relations":[{"id":"R1383","pred":"arg1Of","subj":"T1366","obj":"T1365"},{"id":"R1385","pred":"arg2Of","subj":"T1368","obj":"T1367"},{"id":"R40112","pred":"arg1Of","subj":"T3174","obj":"T8430"},{"id":"R77404","pred":"arg1Of","subj":"T3174","obj":"T27555"},{"id":"R67045","pred":"arg2Of","subj":"T80657","obj":"T27555"},{"id":"R19042","pred":"arg1Of","subj":"T80657","obj":"T55541"},{"id":"R70679","pred":"arg1Of","subj":"T80657","obj":"T20248"},{"id":"R98963","pred":"arg1Of","subj":"T80657","obj":"T67286"},{"id":"R51375","pred":"arg1Of","subj":"T80657","obj":"T69498"},{"id":"R65034","pred":"arg1Of","subj":"T80657","obj":"T3932"},{"id":"R38518","pred":"arg1Of","subj":"T80657","obj":"T49427"},{"id":"R18142","pred":"arg1Of","subj":"T80657","obj":"T46816"},{"id":"R95989","pred":"arg1Of","subj":"T80657","obj":"T99370"},{"id":"R21203","pred":"arg2Of","subj":"T83381","obj":"T99370"},{"id":"R62409","pred":"arg1Of","subj":"T83381","obj":"T82158"},{"id":"R45278","pred":"arg1Of","subj":"T83381","obj":"T40184"},{"id":"R36808","pred":"arg1Of","subj":"T99370","obj":"T34922"},{"id":"R25095","pred":"modOf","subj":"T99370","obj":"T41135"},{"id":"R66468","pred":"arg1Of","subj":"T41135","obj":"T52094"},{"id":"R61128","pred":"arg2Of","subj":"T66049","obj":"T52094"},{"id":"R69033","pred":"arg1Of","subj":"T66049","obj":"T41086"},{"id":"R63943","pred":"arg1Of","subj":"T66049","obj":"T24478"},{"id":"R16751","pred":"arg1Of","subj":"T66049","obj":"T12116"},{"id":"R91171","pred":"arg1Of","subj":"T80516","obj":"T24089"},{"id":"R35674","pred":"modOf","subj":"T41135","obj":"T24089"},{"id":"R17624","pred":"arg2Of","subj":"T40146","obj":"T80516"},{"id":"R94826","pred":"arg1Of","subj":"T80516","obj":"T31245"},{"id":"R46405","pred":"arg2Of","subj":"T10989","obj":"T31245"},{"id":"R49465","pred":"arg1Of","subj":"T10989","obj":"T10149"},{"id":"R67827","pred":"arg1Of","subj":"T10989","obj":"T79574"},{"id":"R10702","pred":"arg1Of","subj":"T10989","obj":"T93688"},{"id":"R76944","pred":"arg1Of","subj":"T10989","obj":"T94198"},{"id":"R27221","pred":"arg2Of","subj":"T81817","obj":"T32196"},{"id":"R83664","pred":"arg3Of","subj":"T52822","obj":"T32196"},{"id":"R29301","pred":"arg1Of","subj":"T52822","obj":"T91723"}],"text":"RS glycan shields by cryo-EM\nHIV-1 Env is a prototypic viral class I fusion protein that exhibits extensive surface glycosylation, resulting in an effective glycan shield to aid evasion from the host adaptive immune response21,31. In order to visualize t"}
LitCovid-sample-PD-FMA
{"project":"LitCovid-sample-PD-FMA","denotations":[{"id":"T99","span":{"begin":29,"end":32},"obj":"Body_part"},{"id":"T100","span":{"begin":76,"end":83},"obj":"Body_part"}],"attributes":[{"id":"A99","pred":"fma_id","subj":"T99","obj":"http://purl.org/sig/ont/fma/fma278683"},{"id":"A100","pred":"fma_id","subj":"T100","obj":"http://purl.org/sig/ont/fma/fma67257"}],"text":"RS glycan shields by cryo-EM\nHIV-1 Env is a prototypic viral class I fusion protein that exhibits extensive surface glycosylation, resulting in an effective glycan shield to aid evasion from the host adaptive immune response21,31. In order to visualize t"}
LitCovid-sample-CHEBI
{"project":"LitCovid-sample-CHEBI","denotations":[{"id":"T135","span":{"begin":76,"end":83},"obj":"Chemical"}],"attributes":[{"id":"A135","pred":"chebi_id","subj":"T135","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"}],"text":"RS glycan shields by cryo-EM\nHIV-1 Env is a prototypic viral class I fusion protein that exhibits extensive surface glycosylation, resulting in an effective glycan shield to aid evasion from the host adaptive immune response21,31. In order to visualize t"}
LitCovid-sample-PD-NCBITaxon
{"project":"LitCovid-sample-PD-NCBITaxon","denotations":[{"id":"T124","span":{"begin":29,"end":34},"obj":"Species"}],"attributes":[{"id":"A124","pred":"ncbi_taxonomy_id","subj":"T124","obj":"NCBItxid:11676"}],"namespaces":[{"prefix":"NCBItxid","uri":"http://purl.bioontology.org/ontology/NCBITAXON/"}],"text":"RS glycan shields by cryo-EM\nHIV-1 Env is a prototypic viral class I fusion protein that exhibits extensive surface glycosylation, resulting in an effective glycan shield to aid evasion from the host adaptive immune response21,31. In order to visualize t"}
LitCovid-sample-sentences
{"project":"LitCovid-sample-sentences","denotations":[{"id":"T103","span":{"begin":29,"end":230},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"RS glycan shields by cryo-EM\nHIV-1 Env is a prototypic viral class I fusion protein that exhibits extensive surface glycosylation, resulting in an effective glycan shield to aid evasion from the host adaptive immune response21,31. In order to visualize t"}
LitCovid-sample-Pubtator
{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"602","span":{"begin":3,"end":9},"obj":"Chemical"},{"id":"661","span":{"begin":29,"end":34},"obj":"Species"},{"id":"656","span":{"begin":35,"end":38},"obj":"Gene"},{"id":"671","span":{"begin":157,"end":163},"obj":"Chemical"}],"attributes":[{"id":"A602","pred":"pubann:denotes","subj":"602","obj":"MESH:D011134"},{"id":"A661","pred":"pubann:denotes","subj":"661","obj":"Tax:11676"},{"id":"A656","pred":"pubann:denotes","subj":"656","obj":"Gene:64006"},{"id":"A671","pred":"pubann:denotes","subj":"671","obj":"MESH:D011134"}],"text":"RS glycan shields by cryo-EM\nHIV-1 Env is a prototypic viral class I fusion protein that exhibits extensive surface glycosylation, resulting in an effective glycan shield to aid evasion from the host adaptive immune response21,31. In order to visualize t"}
LitCovid-sample-UniProt
{"project":"LitCovid-sample-UniProt","denotations":[{"id":"T3769","span":{"begin":35,"end":38},"obj":"Protein"}],"attributes":[{"id":"A3769","pred":"uniprot_id","subj":"T3769","obj":"https://www.uniprot.org/uniprot/C1JJY3"},{"id":"A3770","pred":"uniprot_id","subj":"T3769","obj":"https://www.uniprot.org/uniprot/P24123"}],"text":"RS glycan shields by cryo-EM\nHIV-1 Env is a prototypic viral class I fusion protein that exhibits extensive surface glycosylation, resulting in an effective glycan shield to aid evasion from the host adaptive immune response21,31. In order to visualize t"}
LitCovid-sample-PD-GO-BP-0
{"project":"LitCovid-sample-PD-GO-BP-0","denotations":[{"id":"T38","span":{"begin":116,"end":129},"obj":"http://purl.obolibrary.org/obo/GO_0070085"}],"text":"RS glycan shields by cryo-EM\nHIV-1 Env is a prototypic viral class I fusion protein that exhibits extensive surface glycosylation, resulting in an effective glycan shield to aid evasion from the host adaptive immune response21,31. In order to visualize t"}
LitCovid-sample-GO-BP
{"project":"LitCovid-sample-GO-BP","denotations":[{"id":"T35","span":{"begin":116,"end":129},"obj":"http://purl.obolibrary.org/obo/GO_0070085"}],"text":"RS glycan shields by cryo-EM\nHIV-1 Env is a prototypic viral class I fusion protein that exhibits extensive surface glycosylation, resulting in an effective glycan shield to aid evasion from the host adaptive immune response21,31. In order to visualize t"}
LitCovid-PD-GO-BP
{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T39","span":{"begin":116,"end":129},"obj":"http://purl.obolibrary.org/obo/GO_0070085"}],"text":"RS glycan shields by cryo-EM\nHIV-1 Env is a prototypic viral class I fusion protein that exhibits extensive surface glycosylation, resulting in an effective glycan shield to aid evasion from the host adaptive immune response21,31. In order to visualize t"}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T103","span":{"begin":29,"end":230},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"RS glycan shields by cryo-EM\nHIV-1 Env is a prototypic viral class I fusion protein that exhibits extensive surface glycosylation, resulting in an effective glycan shield to aid evasion from the host adaptive immune response21,31. In order to visualize t"}